IP Library Granted Patent US 9,145,376
Granted Patent B2
US 9,145,376 · App. 13/980,527 · Granted Sep 29, 2015

Quinazolinone inhibitors of dynein

Inventors: James K. Chen (Mountain View, CA); Tarun M. Kapoor (New York, NY); Ari J. Firestone (San Mateo, CA); Joshua S. Weinger (New York, NY)
Assignee: The Rockefeller University
C07D239/91A61K31/517
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,145,376
App. No.
13/980,527
Granted
Sep 29, 2015
Kind
B2
Abstract

Compounds of formula (I) in which R 3 is chosen from hydrogen, cyano, nitro, acetyl and C(═O)NH 2 , and Ar is optionally substituted monocyclic or bicyclic aryl or heteroaryl, are useful as antitumor agents.

Claims (36)

1. A compound of formula

wherein

R 1 is chosen from —(C 3 -C 10 )hydrocarbon, —O—(C 3 -C 6 )alkyl, and -A-R 10 , wherein A is a (C 1 -C 6 )hydrocarbon and R 10 is chosen from —O—(C 1 -C 6 )alkyl, fluoro(C 1 -C 6 )alkyl, —O—(C 1 -C 6 )fluoroalkyl, hydroxy, —CN, nitro, —S—(C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )acyl, amino, (C 1 -C 6 )alkylamino, di(C 1 -C 6 )alkylamino and (C 1 -C 6 )acylamino; and R 2 is hydrogen;

R 3 is chosen from cyano, nitro, acetyl and —C(═O)NH 2 ;

R 4 and R 5 are independently chosen from hydrogen and methyl;

Y is O;

and

Ar is chosen from;

a. phenyl substituted with from one to three substituents independently chosen from halogen, (C 1 -C 10 )hydrocarbon, fluoro(C 1 -C 6 )alkyl, —O(C 1 -C 6 )fluoroalkyl, —CN, nitro, (C 1 -C 6 )alkoxycarbonyl and (C 1 -C 6 )acyl; and

b. naphthyl, and thiophenyl, either of which may be optionally substituted with from one to three substituents independently chosen from halogen, (C 1 -C 10 )hydrocarbon, fluoro(C 1 -C 6 )alkyl, —O(C 1 -C 6 )fluoroalkyl, —CN, nitro, (C 1 -C 6 )alkoxycarbonyl and (C 1 -C 6 )acyl.

2. A compound according to claim 1 wherein Ar is chosen from substituted phenyl and naphthyl, and thiophenyl, any of which may be optionally substituted with from one to three substituents independently chosen from halogen, (C 1 -C 10 )hydrocarbon, fluoro(C 1 -C 6 )alkyl, —O—(C 1 -C 6 )fluoroalkyl, —CN, nitro, (C 1 -C 6 )alkoxycarbonyl and (C 1 -C 6 )acyl.

3. A compound according to claim 2 wherein Ar is phenyl substituted with from one to three halogens.

4. A compound according to claim 3 wherein Ar is 2,4-dichlorophenyl or 3,4-dichlorophenyl.

5. A compound according to claim 1 wherein R 4 and R 5 are hydrogen.

6. A compound according to claim 1 wherein R 3 is CN.

7. A compound according to claim 4 wherein R 3 is CN; and R 2 , R 4 and R 5 are H.

8. A method of inhibiting a dynein comprising bringing said dynein into contact with a compound of formula

wherein

R 1a is —(C 3 -C 10 )hydrocarbon, or —O—(C 3 -C 6 )alkyl; and

R 6 and R 7 are halogen.

9. A method of inhibiting retrograde cilial transport comprising bringing a cell having at least one cilium into contact with a compound of formula

wherein

R 1a is —(C 3 -C 10 )hydrocarbon, or —O—(C 3 -C 6 )alkyl; and

R 6 and R 7 are halogen.

10. A method according to claim 9 wherein said method of inhibiting is an in vitro method.

11. A method according to claim 9 wherein said method of inhibiting is an in vivo method.

12. A method of inhibiting the growth of a basal cell carcinoma, glioblastoma or medulloblastoma comprising bringing said basal cell carcinoma, glioblastoma or medulloblastoma into contact with a compound of formula

wherein

R 1 is chosen from —(C 3 -C 10 )hydrocarbon, —O—(C 3 -C 6 )alkyl, and -A-R 10 , wherein A is a (C 1 -C 6 )hydrocarbon and R 10 is chosen from —O—(C 1 -C 6 )alkyl, fluoro(C 1 -C 6 )alkyl, —O—(C 1 -C 6 )fluoroalkyl, hydroxy, —CN, nitro, —S—(C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )acyl, amino, (C 1 -C 6 )alkylamino, di(C 1 -C 6 )alkylamino and (C 1 -C 6 )acylamino; and R 2 is hydrogen;

R 3 is chosen from hydrogen, cyano, nitro, acetyl and —C(═O)NH 2 ;

R 4 and R 5 are independently chosen from hydrogen and methyl;

Y is O;

and

Ar is chosen from:

a. phenyl substituted with from one to three substituents independently chosen from halogen, (C 1 -C 10 )hydrocarbon, fluoro(C 1 -C 6 )alkyl, —O(C 1 -C 6 )fluoroalkyl, —CN, nitro, (C 1 -C 6 )alkoxycarbonyl and (C 1 -C 6 )acyl; and

b. naphthyl, and thiophenyl, either of which may be optionally substituted with from one to three substituents independently chosen from halogen, (C 1 -C 10 )hydrocarbon, fluoro(C 1 -C 6 )alkyl, —O(C 1 -C 6 )fluoroalkyl, —CN, nitro, (C 1 -C 6 )alkoxycarbonyl and (C 1 -C 6 )acyl.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 12, 2013
From: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031805/0225 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2013
From: CHEN, JAMES K.; FIRESTONE, ARI J.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 030976/0193 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2013
From: WEINGER, JOSHUA S.; KAPOOR, TARUN M.
To: THE ROCKEFELLER UNIVERSITY
Reel/Frame 030979/0553 →
Continuity (2)
Provisional Application 61434545 · Jan 20, 2011
Related Publication 20130296349A1 · Nov 7, 2013